Herbas VPB

Print
EN | LT
LT - DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS
EN - DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/68
G01N 33/92
European patent
(11) Number of the document 3489689
(13) Kind of document T
(96) European patent application number 18195687.1
Date of filing the European patent application 2005-12-20
(97) Date of publication of the European application 2019-05-29
(45) Date of publication and mention of the grant of the patent 2020-06-17
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
637503 P 2004-12-20 US
719307 P 2005-09-21 US
Inventors
(72)
Uttenthal, Lars Otto, ES
Juanes, Margarita Ghiglione, ES
Bangert, Kristian, DK
Grantee
(73) Antibodyshop A/S, Grusbakken 8, 2820 Gentofte, DK
Title
(54) DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS
  DETERMINATION OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A DIAGNOSTIC MARKER FOR RENAL DISORDERS
Last update date 2021-04-30